1. Home
  2. HOFT vs UNCY Comparison

HOFT vs UNCY Comparison

Compare HOFT & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hooker Furnishings Corporation

HOFT

Hooker Furnishings Corporation

N/A

Current Price

$13.99

Market Cap

152.5M

ML Signal

N/A

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

N/A

Current Price

$4.78

Market Cap

145.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HOFT
UNCY
Founded
1924
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.5M
145.3M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
HOFT
UNCY
Price
$13.99
$4.78
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$25.67
AVG Volume (30 Days)
58.3K
1.9M
Earning Date
04-16-2026
05-13-2026
Dividend Yield
3.79%
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$278,139,000.00
$675,000.00
Revenue This Year
$17.37
N/A
Revenue Next Year
$9.00
$582.86
P/E Ratio
$138.70
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.62
$3.72
52 Week High
$18.09
$8.74

Technical Indicators

Market Signals
Indicator
HOFT
UNCY
Relative Strength Index (RSI) 42.32 37.27
Support Level $11.99 $4.28
Resistance Level $15.97 $5.39
Average True Range (ATR) 0.80 0.30
MACD -0.15 0.03
Stochastic Oscillator 26.60 9.62

Price Performance

Historical Comparison
HOFT
UNCY

About HOFT Hooker Furnishings Corporation

Hooker Furnishings Corp is a designer, marketer, and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality, and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segments: Hooker Branded segment, Domestic Upholstery segment, and All Other. It generates the majority of its revenue from the Hooker Branded segment.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: